BOLTON SECURITIES CORPORATION’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$130K Sell
3,143
-8
-0.3% -$348 ﹤0.01% 1045
2026
Q2
$134K Buy
3,151
+1,274
+68% +$56.9K 0.01% 1029
2026
Q1
$90.4K Buy
+1,877
New +$87.5K ﹤0.01% 1057
2025
Q3
$85K Buy
+1,800
New +$86.9K ﹤0.01% 1022
2025
Q1
$98.3K Buy
+1,772
New +$95.9K 0.01% 881

Other funds holding SNY

BOLTON SECURITIES CORPORATION's SNY Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Sanofi (SNY) stake by 0.25% in Q3 2026, selling an estimated $348 and leaving 3,143 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

BOLTON SECURITIES CORPORATION first reported a position in SNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $134K in Q2 2026. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 3,143 shares of Sanofi worth $130K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION sold 8 Sanofi shares in Q3 2026, an estimated $348.
  • Sanofi made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1045 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Sanofi in Q1 2025 and has held it in 5 quarters since.
  • BOLTON SECURITIES CORPORATION's Sanofi position peaked at $134K in Q2 2026.
  • 485 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.